Economic burden of varicella and cost-benefit analysis of vaccine immunization in Honggutan district of Nanchang

TU Zheng-bo; XU Qun-ying; WAN Gang-feng; NIE Ping-ying

doi:10.19568/j.cnki.23-1318.2019.02.006

Abstract：Objective To analyze the economic burden of varicella cases and the benefits-cost of varicella vaccine immunization in Honggutan district of Nanchang, provide evidence for formulating public health strategies.Methods Stratified random sampling method was used to select 228 patient cases of varicella with reported in Honggutan district from 2016 to 2017.Information about economic cost of varicella cases were gathered and estimated by questionnaire survey.According to the investigation of varicella vaccination and the economic burden of cases, the cost, benefit and benefit-cost ratio of chickenpox vaccine immunization were evaluated and analyzed.Results The total economic burden per capita of 228 varicella cases was (1 263.56±457.47) yuan, including (166.64±25.97) yuan for direct medical expenses, (117.61±15.81) yuan for direct non-medical expenses and (979.48±430.74) yuan for indirect economic losses.The average annual cost of varicella vaccine immunization in Honggutan new district from 2016 to 2017 was 746 200 yuan, and the direct benefit was 872 481 yuan, the direct benefit-cost ratio was 1.17, the overall benefit was 3 880 709 yuan, and the overall benefit-cost ratio was 5.20.Conclusion The economic burden of the case of varicella patients is heavy, varicella vaccination strategy has favorable benefit-cost ratio.The benefit-cost ratio of varicella vaccine can be increased by the decrease of varicella vaccine price, the increase of protection rate and the increase of varicella incidence.